Editors in Conversation cover art

All Episodes

Editors in Conversation — 122 episodes

#
Title
1

Diagnostic Access and Equity

2

Gram-Negative Resistance: A Decade of Evolution with Laurent Poirel, Ph.D.

3

Technology and Discovery in Modern Microbiology

4

Cyclospora In The Lab

5

Next Gen Careers in Clinical Microbiology

6

AI and Antibiotic Discovery

7

Why Your Lab QC Might Be Missing Critical Errors

8

Phage JS1: The Virus Breaking the Rules

9

Urine-based Testing to Detect HPV

10

The Aerobiome - The Hidden Biology of Air

11

Harnessing MALDI-TOF for MICs

12

Fungi in a Warming World: Climate, Candida auris, and the Next Microbial Frontier - with Arturo Casadevall, M.D., Ph.D.

13

Best AMR papers of 2025: A Collaboration between AAC and JID for IMARI

14

Green Labs

15

Rising Antimicrobial Resistance in The Microbial Universe

16

Favorite Clinical Microbiology Papers of 2025

17

Clinical Trials With the Potential To Change the Management of Prosthetic Joint Infections

18

Metabolomics

19

The First OTC Syphilis Test: Clinical Performance and Impact

20

Artificial Intelligence in the Microbiology Laboratory (JCM ed.)

21

What Makes a Great Mini-review? (JCM ed.)

22

Emerging Technologies for Rapid Phenotypic AST of Clinical Isolates of Bacteria (JCM ed.)

23

The Rise of Measles (AAC ed.)

24

Meet the New Editor in Chief of the Journal of Clinical Microbiology

25

Static vs Cidal Antibiotics: Concepts Revisited

26

Updated FDA Recognition of CLSI Breakpoints (JCM ed.)

27

Management of Pneumonia: Past, Present and Future

28

Show Me the Light! Uv Light for Cyclospora

29

Best Papers in the Journal of Clinical Microbiology, 2024

30

Best Papers of AAC, 2024

31

Getting a Job in a Clinical Microbiology Lab

32

The Global Antibiotic Research & Development Partnership (GARDP)

33

At-Home Collection and Testing for STIs

34

High Level Meeting on AMR at the United Nations: A Debrief

35

The Launch of ASM Case Reports Journal

36

Heteroresistance: Mechanisms, Diagnosis and Clinical Implications

37

Microbiology in the Headlines: H5N1 in Dairy Cattle, The Plague, Measles, Neosporin and more!

38

The Global Preclinical Antibacterial Pipeline

39

Turning the Output of the Microbiology Laboratory Into Gold

40

Training in Antimicrobial Resistance: Gaps and Opportunities

41

10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles

42

Why Phage Therapy May Fail

43

Is Lophomonas a Pathogen?

44

Treatment of Multidrug-resistant Tuberculosis

45

New generation B-lactam/B-lactamase inhibitors: Taniborbactam

46

Favorite Clinical Microbiology Papers of 2023 (JCM ed.)

47

Antimicrobial Resistance in Neisseria Gonorrhoeae (JCM ed.)

48

New Antifungals (AAC ed.)

49

A Novel Coccidioides Antibody LFA (JCM ed.)

50

Climate Change and Antimicrobial Resistance (AAC ed.)

51

Emerging Antifungal-Resistant Dermatophytes (JCM ed.)

52

Artificial Intelligence and Infectious Diseases (AAC ed.)

53

Viral Outbreaks in the Headlines (JCM ed.)

54

AAC Launches a New Section Focused On Antimicrobial Stewardship (AAC ed.)

55

Susceptibility Testing for Aztreonam with Ceftazidime-Avibactam (JCM ed.)

56

Hispanic Leadership in Vaccine Sciences With Dr. Maria Elena Bottazzi (AAC ed.)

57

Updates on Testing for Vaginitis/Vaginosis (JCM ed.)

58

Management of Difficult to Treat HSV and CMV Infections (AAC ed.)

59

Susceptibility Testing for Piperacillin-Tazobactam (JCM ed.)

60

Antimicrobial Resistance in Neisseria gonorrhoeae (AAC ed.)

61

Avoiding HIV False Positives (JCM ed.)

62

Discussing β-lactamase/β-lactamase inhibitors (AAC ed.)

63

Molecular Testing for Periprosthetic Joint Infections (JCM ed.)

64

An Update on COVID-19 Therapeutics (AAC ed.)

65

The Best Clinical Microbiology Papers of 2022 (JCM Ed.)

66

How Can Clinical Microbiology Labs Contribute to Antimicrobial Stewardship? (JCM ed.)

67

Research Careers in Antimicrobial Resistance (AAC ed.)

68

Machine Learning and Artificial Intelligence in the Clinical Microbiology Laboratory (JCM ed.)

69

How Proposed Change to US Regulation Could Impact Clinical Microbiology Labs (JCM ed.)

70

Management of Mycobacterium Abscessus Infections: The Rise of a Superbug (AAC ed.)

71

The Inoculum Effect of Antibiotic Susceptibility Testing (JCM ed.)

72

Diagnosis and Treatment of Monkeypox (AAC ed.)

73

Dynamite Parasites, with Dr. Bobbi Pritt (JCM ed.)

74

Stenotrophomonas maltophilia: The Silent Rise of a Superbug (AAC ed.)

75

What's New in Molecular Virology? (JCM ed.)

76

Treatment of Resistant Pseudomonas Aeruginosa Infections (AAC ed.)

77

Prevalence and Mortality Associated with Bloodstream Infections (JCM ed.)

78

Consensus on B-lactamases (AAC ed.)

79

Multiplex PCR for Predicting Antibiotic Susceptibility (JCM ed.)

80

Phages as Therapeutic Tools Against Multidrug Resistant Bacteria (AAC ed.)

81

COVID-19 Associated Pulmonary Aspergillosis - The Other CAPA (JCM ed.)

82

WHO Critical Review of the Antibacterial Pipeline (AAC ed.)

83

Testing for COVID-19 During the Age of Omicron (JCM ed.)

84

Best Clinical Microbiology Papers of 2021 (JCM ed.)

85

Treatment of Acinetobacter spp. Infections (AAC ed.)

86

SARS-CoV-2 Sequencing for Clinical Care and Infection Control (JCM ed.)

87

Candida auris at the Intersection of the COVID-19 Pandemic (AAC ed.)

88

COVID-19 Testing - Schools, False Positives, and In-Person Meetings (JCM ed.)

89

Testing for COVID-19 Infectivity (JCM ed.)

90

Treatment of VRE Infections (AAC ed.)

91

Advances in Serologic Testing for COVID-19 (JCM ed.)

92

Innovative Clinical Trials for COVID-19 (AAC ed.)

93

Mythbusting in Susceptibility Testing (JCM ed.)

94

Antimalarial Drug-Resistance (AAC ed.)

95

Staphylococcus argenteus: another coagulase positive Staphylococcus (JCM ed.)

96

β-lactam/β-lactamase inhibitor combinations (AAC ed.)

97

Reconciling Genotypic and Phenotypic Susceptibility Tests (JCM ed.)

98

Gaps in Laboratory Diagnosis of Fungal Diseases (JCM ed.)

99

Pandemic Built Environment (mSystems ed.)

100

Developing Non-Traditional Antibiotics (AAC ed.)

101

Fermentative Food Microbiome (mSystems ed.)

102

Optimizing Blood Cultures with Dr. Eric Ransom and Dr. Valeria Fabre (JCM ed.)

103

Top Non-COVID-19 AAC Papers of 2020: A discussion with early stage investigators (AAC ed.)

104

Susceptibility testing for Staphylococci Other Than S. aureus (JCM ed.)

105

Synthetic Microbiology (mSystems ed.)

106

Vaccines for COVID19: A Critical Appraisal with Dr. Carol Baker (AAC ed.)

107

2020: A Bad Year with Great Papers in Clinical Microbiology (JCM ed.)

108

2020: The year of COVID-19 (AAC ed.)

109

COVID-19: Clinical Labs in the Media Spotlight with Dr. Katherine Wu and Dr. Susan Butler-Wu (JCM ed.)

110

The Antimicrobial Resistance Leadership Group (ARLG) (AAC ed.)

111

Total Laboratory Automation in Clinical Microbiology (JCM ed.)

112

The use of remdesivir against SARS-CoV-2 (AAC ed.)

113

COVID-19 Diagnostic Testing Redux (JCM ed.)

114

Discovering new antibiotics (AAC ed.)

115

Parasites (JCM ed.)

116

The dearth of antibiotic development (AAC ed.)

117

Detection of carbapenemases (JCM ed.)

118

New Vancomycin Guidelines (AAC ed.)

119

COViD-19: Therapeutic Update (AAC ed.)

120

Antimicrobial Agents and Chemotherapy Journal - Past, Present and Future (AAC ed.)

121

Diagnostic Tests for COVID-19 (JCM ed.)

122

Therapeutic approaches for COVID-19: Myths and facts (AAC ed.)